Solara Active Pharma Sciences' Mangalore unit completes USFDA inspection

Last Updated : Nov 19 2025 | 11:31 AM IST

Solara Active Pharma Sciences announced that its multi-product manufacturing facility at Mangalore, Karnataka has successfully completed the inspection carried out by the US Food and Drug Administration (US FDA) between 25 to 29 August 2025. The Agency has issued an EIR (Establishment Inspection Report) on 18th Nov 2025 and determined that the inspection classification of the facility is Voluntary Action Indicated (VAI) and concluded this inspection as closed.

Powered by Capital Market - Live News

Disclaimer: No Business Standard Journalist was involved in creation of this content

Connect with us on WhatsApp

Spectrum Electrical Industries consolidated net profit rises 63.50% in the September 2025 quarter

Tulsyan NEC reports consolidated net loss of Rs 6.09 crore in the September 2025 quarter

Octavius Plantations standalone net profit rises 42.86% in the September 2025 quarter

Taaza International reports standalone net loss of Rs 0.13 crore in the September 2025 quarter

Omni Ax's Software reports standalone net loss of Rs 0.03 crore in the September 2025 quarter

First Published: Nov 19 2025 | 11:07 AM IST